Healthcare entity
Every one of those 2 sits in a single category, medical-devices. Of the tracked stories, 1 of 2 also mention Astellas Pharma, the most common co-covered peer. Source depth averages 4.5 original sources per story, versus 3.1 across the same-window beat baseline.
Last mentioned: Mar 6, 2026
Entity pulse
Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.
Every one of those 2 sits in a single category, medical-devices. Of the tracked stories, 1 of 2 also mention Astellas Pharma, the most common co-covered peer. Source depth averages 4.5 original sources per story, versus 3.1 across the same-window beat baseline. At 5, the average consequence score sits below the same-window beat average of 5.8. This profile follows 2 Healthcare stories mentioning Iota Biosciences across the period from March 5, 2026 to March 6, 2026.
Computed from the 2 stories linked to this entity, with beat comparisons drawn from all 46 Healthcare stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Other entities that clear the same relevance threshold in stories also covering Iota Biosciences. Shared-story counts are live from our verified record — not editorial picks.
2026 NYC Forum
Scheduled date for the Bioelectronic Medicine Forum in New York City.
Forum Announcement
Official announcement of the 2026 Bioelectronic Medicine Forum keynote and presenters.
Astellas Acquisition
Astellas Pharma acquires Iota Biosciences in a deal valued at over $300 million.
Iota Biosciences Founded
Established as a spin-off from UC Berkeley to develop 'neural dust' technology.
The 2026 Bioelectronic Medicine Forum in New York City will feature a keynote from the founder of Iota Biosciences, a leader in miniaturized neural implants. The event highlights a growing international ecosystem of neurotech startups, including Coherence Neuro and Spiro Medical, focused on 'electroceuticals.'
Source: Rutland Herald · Times Argus
The founder of Iota Biosciences has been named the keynote speaker for the 2026 Bioelectronic Medicine Forum in New York City. This announcement highlights the growing prominence of 'neural dust' technology and its potential to revolutionize chronic disease management through ultra-miniature bioelectronic implants.
Source: itnewsonline.com · winknews.com
Iota Biosciences is linked from 2 stories on this site, each scored at or above our 35% relevance threshold — see how these pages are built.
See something wrong on this page — a misattributed entity, a wrong stat, a broken source link? Report a data issue.
